Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Flaherty

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Clinical Advances in Hematology & Oncology : H&O|March 31, 2010
Advances in drug development. BRAF validation in melanomaKeith Flaherty
Clinical Advances in Hematology & Oncology : H&O|October 18, 2017
In the pipeline: encorafenib and binimetinib in BRAF-mutated melanomaKeith Flaherty
Pigment Cell & Melanoma Research|June 24, 2014
The melanoma metastasis X-factorRizwan Haq, Keith Flaherty
Urologic Oncology|September 9, 2008
Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinomaBrian I Rini, Keith Flaherty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Unusual hematologic malignancies. Case 1. Hematologic malignancy presenting with diarrhea and bony lesions: systemic mastocytosisJianguo Tao, Keith Flaherty, Adam Bagg
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Emerging Strategies in Systemic Therapy for the Treatment of MelanomaPaolo A Ascierto, Keith Flaherty, Stephanie Goff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patientsPhyllis A Gimotty, DuPont Guerry, Keith Flaherty
The Lancet. Oncology|October 5, 2015
Disease kinetics for decision-making in advanced melanoma: a call for scenario-driven strategy trialsJean Jacques Grob, Georgina V Long, Dirk Schadendorf, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 4, 2018
Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case SeriesJiahe Zheng, Zubin Irani, Donald Lawrence, et al.
JAMA Dermatology|December 20, 2013
Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanomaJune J Park, Elena B Hawryluk, Steven R Tahan, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Clinical Advances in Hematology & Oncology : H&O|March 31, 2010
Advances in drug development. BRAF validation in melanomaKeith Flaherty
Clinical Advances in Hematology & Oncology : H&O|October 18, 2017
In the pipeline: encorafenib and binimetinib in BRAF-mutated melanomaKeith Flaherty
Pigment Cell & Melanoma Research|June 24, 2014
The melanoma metastasis X-factorRizwan Haq, Keith Flaherty
Urologic Oncology|September 9, 2008
Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinomaBrian I Rini, Keith Flaherty
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Unusual hematologic malignancies. Case 1. Hematologic malignancy presenting with diarrhea and bony lesions: systemic mastocytosisJianguo Tao, Keith Flaherty, Adam Bagg
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Emerging Strategies in Systemic Therapy for the Treatment of MelanomaPaolo A Ascierto, Keith Flaherty, Stephanie Goff
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2008
Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patientsPhyllis A Gimotty, DuPont Guerry, Keith Flaherty
The Lancet. Oncology|October 5, 2015
Disease kinetics for decision-making in advanced melanoma: a call for scenario-driven strategy trialsJean Jacques Grob, Georgina V Long, Dirk Schadendorf, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 4, 2018
Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case SeriesJiahe Zheng, Zubin Irani, Donald Lawrence, et al.
JAMA Dermatology|December 20, 2013
Cutaneous granulomatous eruption and successful response to potent topical steroids in patients undergoing targeted BRAF inhibitor treatment for metastatic melanomaJune J Park, Elena B Hawryluk, Steven R Tahan, et al.
Pageof 7